Core Insights - Neuvotion, Inc. is an early-stage medical device company focused on AI-driven neuromodulation technologies for neurorehabilitation, brain-computer interface, and physical therapy markets [1][4] - The company has expanded its partnership with Intelligent Product Solutions (IPS) to accelerate the market launch of its first product, NeuStim™ [1][2] - Forward Industries, the parent company of IPS, has made an undisclosed investment in Neuvotion to support its growth [1] Company Overview - Neuvotion aims to develop innovative technologies that enhance patient outcomes, independence, and quality of life, particularly for those recovering from stroke or spinal cord injuries [3][4] - The company's technologies integrate high-precision neurostimulation with artificial intelligence to improve the effectiveness and efficiency of rehabilitation [4] Partnership Details - The partnership with IPS is expected to leverage their expertise in medical device design and engineering to bring NeuStim™ to market [3][5] - IPS specializes in all stages of product development, including research, design, and manufacturing, which will support Neuvotion's product launch [5]
Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury